D-0154-2025 Class II Ongoing
FDA drug recall D-0154-2025 was initiated by Macleods Pharmaceuticals Ltd on Nov 25, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: 15,744 30-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 25, 2024
- Initiation Date
- Nov 25, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,744 30-count bottles
Product description
Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.
Reason for recall
Failed Impurities/Degradation Specifications
Distribution pattern
Nationwide in the USA
Code information
Lot# BOB12318A Exp 07/31/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0154-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026